ABRAMS.wiki provides you with genuine shipments, location, competitors, buyers, customers, suppliers, supply chain, products, product portfolio, contacts, employees, turnover of:
Glenmark Pharmaceuticals Inc., US
To whom does Glenmark Pharmaceuticals Inc., US sell?
no data available
Which products does Glenmark Pharmaceuticals Inc., US sell?
no data available
Market analysis methodology:
from raw statistical data to Artificial Intelligence (AI)
ABRAMS world trade wiki as a partner of UN Comtrade (database of the United Nations) as well as the OECD (Organisation for Economic Co-operation and Development) analyzes billions of statistical data as well as freight and customs data using intelligent algorithms as well as Artificial Intelligence (AI) and has developed a "unique business intelligence portal" on this basis (quote UN Comtrade / References).
On this page you will get insights into the market activities of Glenmark Pharmaceuticals Inc., US which have been individually prepared by our research team.
Take a free peak at the latest shipments from your competitor, supplier or customer!
Multi-level supply chain transparency
ABRAMS world trade wiki not only shows direct suppliers and buyers of the first tier (Tier-1). Our tool Supply Chain Intelligence breaks the visibility barrier beyond Tier-1, enabling a comprehensive insight into the entire supply chain network, providing multi-tier transparency with just one click.
View Glenmark Pharmaceuticals Inc., US's Trade Data!
Book a personal meeting and learn how you can use ABRAMS world trade wiki for in-depth analyses of Glenmark Pharmaceuticals Inc., US.
Book your:
Analyze Glenmark Pharmaceuticals Inc., US's Pricing Strategy!
Leverage the transparency of detailed price analyses to make better decisions regarding Glenmark Pharmaceuticals Inc., US.
Track:
Explore the Product Portfolio in Import and Export of Glenmark Pharmaceuticals Inc., US!
Gain valuable insights into new business opportunities with Glenmark Pharmaceuticals Inc., US through comprehensive import and export data.
Now:
Compare Glenmark Pharmaceuticals Inc., US with Similar Companies!
Discover new sales opportunities through precise export and import analyses of competitors like Glenmark Pharmaceuticals Inc., US.
Find:
- Who are the suppliers of Glenmark Pharmaceuticals Inc., US?
The performance of a company depends heavily on its suppliers. Therefore, a reliable network of partners (suppliers, dealers and manufacturers) is elementary. In bills of lading, a total of 69 international suppliers of Glenmark Pharmaceuticals Inc., US could be identified on which the company is relying. One of the suppliers is, for example, the company Glenmark Pharmaceuticals Ltd., which delivered 207 shipments.
Among 4 identified supplying countries, an important source to purchase products from is: India. 4,759 shipments of goods could be identified from this country.
Get an overview of Glenmark Pharmaceuticals Inc., US’s international procurement and its 69 suppliers with Company Transparency
- What does the supply chain of Glenmark Pharmaceuticals Inc., US look like?
Generally you can differentiate the supply chain or supply network of Glenmark Pharmaceuticals Inc., US by two perspectives:
- The supplier side (a so-called Tier-1-supplier is a direct supplier, Tier-2 is a supplier of the Tier-1 supplier, Tier-n is a supplier at any level in the Glenmark Pharmaceuticals Inc., US supply network).
- The buyer side (a so-called Tier-1 buyer is a direct buyer, Tier-2 is a buyer of the Tier-1 buyer, Tier-n is a buyer at any level in the Glenmark Pharmaceuticals Inc., US distribution network).
To ensure business stability and continuity, a supply chain or supply network must be constructed in such a way that external influences can cause as little damage as possible to Glenmark Pharmaceuticals Inc., US. This applies both in the area of procurement (the loss of a supplier must be covered by an alternative supplier) as in the area of sales (the loss of a buyer must be covered by an alternative buyer).
Risks can generally be considered as the non-availability of goods, through cutback or complete halt of production, or the potential loss of business partners, violating compliance rules (e.g. protection of the environment, labor legislation) and thus drop out of the supply network.
This risk should not necessarily be limited to the direct business partner (Tier 1), it involves the entire supply chain, unless sufficient alternative suppliers and buyers have been put in place.
Get an overview of the international supply chain of Glenmark Pharmaceuticals Inc., US (upstream/procurement and downstream/sales) from Tier-1 to Tier-n
E.G.: Tier 1 supplier Glenmark Pharmaceuticals Ltd.
ABRAMS world trade wiki not only shows direct suppliers and customers of the first tier (Tier-1). With just one click in our tool Supply Chain Intelligence you get a comprehensive insight into the supply network with multiple tiers (Tier-n) beyond the first tier.
- Is the supply chain of Glenmark Pharmaceuticals Inc., US stable?
Each tier in the supply chain or supply network on the supplier side of Glenmark Pharmaceuticals Inc., US involves a single risk. The more tiers, the more difficult it is to analyze and monitor the business partners. Suppliers of suppliers are generally unknown, so there is already an increasing risk at the second (Tier 2) level.
If e.g. a first Tier supplier is not adding any value, the supply chain can be shortened and the risk of failure can be minimized by skipping this supplier. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:
Analyze the potential of shortening and therefore stabilizing the supply chain of Glenmark Pharmaceuticals Inc., US
- Which products does Glenmark Pharmaceuticals Inc., US purchase?
Based on the analysis of international bills of lading (bill of lading/ bills of lading/ BOL), a total of 40 different product categories that have been purchased by Glenmark Pharmaceuticals Inc., US, can be identified.
These are classified by means of HS codes (HTS codes or customs tariff numbers).
For example, HS code 300490 classifies the following products:
„Medicaments consisting of mixed or unmixed products for therapeutic or prophylactic purposes, put up in measured doses "incl. those in the form of transdermal administration" or in forms or packings for retail sale (excl. medicaments containing antibiotics, medicaments containing hormones or steroids used as hormones, but not containing antibiotics, medicaments containing alkaloids or derivatives thereof but not containing hormones or antibiotics and medicaments containing provitamins, vitamins or derivatives thereof used as vitamins)". This HS code was sighted 2,308 times in total.
From the product descriptions of the analyzed bills of lading (bill of lading/ bills of lading/ BOL), the following purchased products from various suppliers can be identified as examples:
-
PHARMCEUTICAL COMMODITY
-
PHARMACEUTICAL COMMODITY.
-
PHARMACEUTICAL COMMODTIY
-
PHARMACEUTICALS PRODUCTS
-
6 PALLETS 511 CARTONS PHAR MACEUTICALS AS UNDER ATOVAQ UONE OS 750MG/5ML 210ML NDC CODE:68462042121 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO. : 209685 USED TO PREVENT OR TREAT A SERIOUS LUNG INFECTION CALLED PNEUMOCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP INFECTION SYMPTOMS SUCH AS FEVER, COUGH, TIREDNESS, AND SHORTNESS OF BREATH . COMMERCIAL & CUSTOM INVOICE NO. F22435002400 DT. 31.08 .2023 S/BILL NO: 3757009 DT 6-SEP-2023 NET WT. 1876.392 K GS 06 DATA LOGGERS SET TEMPERATURE +18 DEGREES NOTIFY PARTY:2 GLENMARK SPECIALTY S.A. SWITZERLAND (GSSA) PLACE DU PORT NEUCHATEL 20 00 SWITZERLAND
-
PHARMACEUTICALS AS UNDER POTASSIUM CL ER CAP 10MEQ 500 NDC CODE:68462035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3004 .90.92.90 ANDA NO.: 202868 THERAPEUTICE USE : TREATMENT OR PREVENTION OF HYPOKALEMIA FENOFIBRATE CAP 200MG 100 NDC CODE:684620 58201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T . S NO.: 3004.90.92.20 ANDA NO.: 205566 TH ERAPEUTICE USE: INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA
-
PHARMACEUTICALS AS UNDER ATOVAQUONE OS 750 MG/5ML 210ML NDC CODE:68462042121 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004 .90.92.90 ANDA NO.: 209685 USED TO PREVENT OR TREAT A SERIOUS LUNG INFECTION CALLED PN EUMOCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP INFECTION SYMPTOMS SUCH AS FEVER, COUGH, TIREDNESS, AND SHORTNESS OF BREATH. ATOVAQUONE OS 750MG/5ML 210ML NDC CODE:68462042121 FDA PRODUCT CODE NO.: 62 L C L 44 H. T. S NO.: 3004.90.92.90 ANDA NO. : 209685 USED TO PREVENT OR TREAT A SERIOUS LUNG INFECTION CALLED PNEUMOCYSTIS PNEUMONIA (PCP). THIS MEDICATION HELPS TO STOP INFECTION SYMPTOMS SUCH AS FEVER, COUGH, TIREDNESS, AND SHORTNESS OF BREATH.
-
PHARMACEUTICALS AS UNDER TACROLIMUS OINT 0 .1% 100GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49 .00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG 100 NDC CODE:68462068301 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.15 ANDA NO.: 208691 THERAPE UTICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. PIMECROLIMUS CREAM 1% 60GM ND C CODE:68462060965 FDA PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: AS SECOUND- LINE THERAPY FOR THE SHORT-TERM AND NON-CON TINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NON IMMUNOCOMPROMIS ED ADULT AND CHILDREN YEARS OF AGE POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035 701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THER APEUTICE USE: TREATMENT OR PREVENTION OF HYPOKALEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68462035701 FDA PRODUCT CODE NO. :65 R C F 14 H. T. S NO.: 3004.90.92.90 AN DA NO.:202868 THERAPEUTICE USE: TREATMENT OR PREVENTION OF HYPOKALEMIA EZETIMIBE TAB 10MG 500 NDC CODE:68462022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004 .49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWERING AGENT EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOWERING AGENT
-
PHARMACEUTICALS AS UNDER CARVEDILOL TAB 25 MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST 00 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE +18 DEGREES TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES
-
PHARMACEUTICALS AS UNDER EZETIMIBE TAB 10M G 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.1 0 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWERING AGENT GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 AND A NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT TACROLIMUS OINT 0.1% 30GM NDC CODE:68462053435 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO .: 210393 THERAPEUTICE USE: TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90. 92.30 ANDA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT PRAVASTATIN SOD TAB 8 0MG 90 NDC CODE:68462019890 FDA PRODUCT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92 .20 ANDA NO.:-77-987 THERAPEUTICE USE:-HYP OLIPDAEMIC EZETIMIBE-SIMVA TAB 10/10MG 90 NDC CODE:68462032190 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 AN DA NO.: 208699 THERAPEUTICE USE: THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. EZETIMIBE-SIMVA TAB 10/20MG 90 NDC CODE:68462032290 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 A NDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOWERING AGENT EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO .: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTICE USE: :#LIPID LOWERING AGENT INDOMETHACIN ER CAP 75MG 6 0 NDC CODE:68462032560 FDA PRODUCT CODE: 62 GCE42 H. T. S NO.:3004.90.92.40 ANDA NO. 203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). THIS EFFECT HELPS TO DECREASE SWELLING AND PAIN. EZETI MIBE-SIMVA TAB 10/20MG 30 NDC CODE:684620322 30 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THE RAPEUTICE USE: :#LIPID LOWERING AGENT 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE +18 DEGREES TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES
Get an overview of internationally purchased products by Glenmark Pharmaceuticals Inc., US with Company Transparency
-
- Is Glenmark Pharmaceuticals Inc., US able to reduce costs in the upstream supply chain?
Each tier in the supply chain or supply network of Glenmark Pharmaceuticals Inc., US is adding value and therefore costs. The more tiers, the more expensive the product gets. Supply chains are normally not very transparent, trade secrets are part of the survival tactics in each stage of the value chain, especially for trading companies.
If e.g. a Tier-1 supplier from Glenmark Pharmaceuticals Inc., US that primarily trades a product and doesn’t add any value (only fulfills the distributor function) it is possible to shorten the supply chain and reduce purchasing costs. A previous Tier-2 supplier now turns into a Tier-1 supplier, which we call "go-direct". In our tool Supply Chain Intelligence as far as international suppliers are concerned, this analysis can be done with one click:
Analyze the potential of shortening the supply chain of Glenmark Pharmaceuticals Inc., US and saving costs on the procurement side.
Purchase- Is Glenmark Pharmaceuticals Inc., US a reliable supplier?
Each company contributes significantly minimizing risks for its buyers, through its own stability. Internal risks (endogenous factors) can be e.g. financially (financial ratios, free cash flow, balance sheets) or operationally (production, lead times). Since 2021, external risks have increased due to worldwide shortages and are an important factor as to whether a supplier such as Glenmark Pharmaceuticals Inc., US can itself reliably deliver due to external dependencies (exogenous factors).
To assess this, data analysis should be conducted to get practical answers:
How is the supply chain or supply network structured on the supplier side of Glenmark Pharmaceuticals Inc., US? Are there suppliers or products in the supply chain that are reported as critical, e.g. in international media?
- Does Glenmark Pharmaceuticals Inc., US have procurement problems at the moment?
The more constant incoming shipments, the better one can determine possible procurement problems of a company like Glenmark Pharmaceuticals Inc., US
Since 2021, there are increasingly external factors due to global supply shortages, whether a company, no matter manufacturer or distributor, can reliably deliver through dependencies.
Based on the statistical trend of shipments (in terms of the number of shipments and respectively the quantity of goods) it is possible to analyze current procurement stability and thus ultimately also to derive an indication of the company’s delivery and performance capability.
Here you can see an analysis of shipments from international suppliers to Glenmark Pharmaceuticals Inc., US in the last few months with Company Transparency
Reliability- What is the CO₂ footprint and sustainability of Glenmark Pharmaceuticals Inc., US products?
Sourcing products as regionally as possible with short shipping routes and the use of sustainable materials define the CO₂ footprint and sustainability of the products of any company, including Glenmark Pharmaceuticals Inc., US
After many companies, predominantly due to cost savings, have been building their networks increasingly internationally for years, there is now an increasing trend of so-called “on-shoring” or “near-shoring”. Attempting to include suppliers who are the closest to the supply chain because of financial, risk, environmental and image aspects:
- Saving international freight costs, which have risen extremely since 2021.
- Minimizing risks caused by logistics problems (e.g. the Suez Canal obstruction in 2021)
- Attempting to reduce the carbon footprint when purchasing products.
- Setting and meeting sustainability goals for own products of Glenmark Pharmaceuticals Inc., US
Based on the development of current shipments (in terms of number of shipments and quantity of goods) and changes in international suppliers and routes, it is possible to analyze the extent to which Glenmark Pharmaceuticals Inc., US has already made efforts in recent months and years, to focus on environmentally relevant aspects, like carbon footprint and sustainability in its business activities.
Get an overview of the international shipments that have an impact on the CO₂ footprint, as well as the sustainability of Glenmark Pharmaceuticals Inc., US
Sustainability- Who are the competitors of Glenmark Pharmaceuticals Inc., US?
Generally you can differentiate the competition of Glenmark Pharmaceuticals Inc., US by the purchase and sales perspective.
- Start the competitive analysis on the purchase side.
- Start the competitive analysis on the sales side.
- Who are the competitors of Glenmark Pharmaceuticals Inc., US on the purchase side?
Competitors of Glenmark Pharmaceuticals Inc., US on the purchase side (procurement of raw materials and components for production or distribution) are exposed on ABRAMs wiki under Competitive Intelligence, purchased products, classified by HS-Codes (e.g. 300490, 300660) or by top product terms.
- Who are the competitors of Glenmark Pharmaceuticals Inc., US on the sales side (selling similar products)?
Competitors on the sales side of Glenmark Pharmaceuticals Inc., US (selling raw materials or components for production or distribution) are exposed on ABRAMS wiki under Competitive Intelligence, sold products classified by HS-Codes or by top product terms.
Competitors
Which companies buy similar products like Glenmark Pharmaceuticals Inc., US?
Following companies buy similar products like Glenmark Pharmaceuticals Inc., US:
